Name (Synonyms) | Correlation |
---|
There is one clinical trial.
To evaluate the incidence of patients with a positive test for SARS-CoV-2, performed in the preoperative screening for patients treated at the institution
Description: Describe the incidence of patients with a positive test for SARS-CoV-2, detected in the preoperative screening program in our center
Measure: Incidence of patients with a positive test for SARS-CoV-2, detected in the preoperative screening program Time: May- December 2020Description: Describe the incidence of SARS-CoV-2 infection in the postoperative period in patients with negative screening test.
Measure: Incidence of SARS-CoV-2 infection in the postoperative period in patients with negative screening test; Time: Up to 30 daysDescription: Postoperative complications will be recorded, according to the Clavien-Dindo classification.
Measure: Postoperative complications Time: Up to 30 daysDescription: To evaluate the risk of all-cause mortality
Measure: Mortality Time: 30 daysDescription: Assess the impact of delayed cancer treatment
Measure: Delay in the cancer treatment Time: May 2020- March 2021